In a major development, the UK government said that it will soon add Bharat Biotech's Covaxin to the list of approved Covid-19 vaccines for international travellers.
Covaxin will be added to the UK's list of approved Covid-19 vaccines from November 22. With this, those vaccinated with the Bharat Biotech's Covaxin will not have to self-isolate after arrival in England.
The development comes following the World Health Organisation's (WHO) approval for Covaxin, the second most used vaccine in India.
Last month, Covishield was added to the UK's approved list.
"More good news for Indian travellers to the UK. From 22 November travellers fully vaccinated with a COVID19 vaccine recognised by WHO for Emergency Use Listing, including Covaxin, will not have to self-isolate; so joining those fully vaccinated with Covishield," Alex Ellis, British High Commissioner to India, said on Twitter on Monday.
The development will come into effect at 4 am on November 22.
Besides Covaxin, China's Sinovac and Sinopharm, will also be recognised by the UK government as approved vaccines. These fully vaccinated travellers will not be required to take a pre-departure test, day-8 test or self-isolate upon arrival.